International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.


Autoria(s): Kotton C.N.; Kumar D.; Caliendo A.M.; Asberg A.; Chou S.; Snydman D.R.; Allen U.; Humar A.; Transplantation Society International CMV Consensus Group
Data(s)

2010

Resumo

Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.

Identificador

https://serval.unil.ch/?id=serval:BIB_9D64B7D1DA72

isbn:1534-6080 (Electronic)

pmid:20224515

doi:10.1097/TP.0b013e3181cee42f

isiid:000276807100002

Idioma(s)

en

Fonte

Transplantation, vol. 89, no. 7, pp. 779-795

Palavras-Chave #Adult; Antiviral Agents/therapeutic use; Child; Consensus; Consensus Development Conferences as Topic; Cytomegalovirus Infections/diagnosis; Cytomegalovirus Infections/drug therapy; Cytomegalovirus Vaccines; Drug Resistance, Viral; Evidence-Based Medicine; Humans; Immunosuppressive Agents/adverse effects; International Cooperation; Organ Transplantation/adverse effects; Risk Assessment; Risk Factors; Treatment Outcome
Tipo

info:eu-repo/semantics/review

article